INTRODUCTION
The glutathione S-transferases (GSTs) are a large family of proteins that catalyse the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds. Although many substrates are xenobiotics, some endogenously derived products of oxygen metabolism, such as the lipid hydroperoxides and the alkenals, have been shown to be substrates for particular GST isoenzymes [1, 2] . In addition to their catalytic activities, some GSTs have been shown to bind a number of hydrophobic compounds, including bilirubin, haem and steroid hormones [3, 4] . The role of GSTs in the metabolism of toxic substances has led to their implication in both susceptibility to carcinogens [5, 6] and the development of resistance to drugs, pesticides, herbicides and antibiotics [1, 7] .
The GSTs are a diverse superfamily, and in mammals the cytosolic GSTs have been grouped into the Alpha, Mu, Pi, Sigma, Theta and Zeta classes [8] [9] [10] [11] . There are multiple enzymes within each of the Alpha, Mu and Theta classes that are the products of distinct gene loci. In contrast, the variant isoenzymes in the human Pi and Zeta classes appear to be allelic.
To date, two human Theta-class isoenzymes, GSTT1-1 [12] and GSTT2-2 [13, 14] , have been identified. Although these two enzymes have a number of features in common, they share only 55 % amino acid sequence identity. These isoenzymes represent the two Theta subclasses that have been identified in mammals [15] . The human enzyme GSTT1-1 is orthologous to the rat 5-5 [9] and mouse mGST T1-1 [16] enzymes, while the human enzyme GSTT2-2 is orthologous to rat yrs-yrs [17] , rat 12-12 [9] and mouse mGST T2-2 [15] .
Compared with the other classes, the Theta-class isoenzymes have a number of distinct characteristics, including their inability to bind to glutathione affinity matrices and their distinct substrate specificities. Dichloromethane and related compounds appear to be significant substrates for GSTT1-1, while GSTT2-2 is most active towards cumene hydroperoxide, ethacrynic acid and menaphthyl sulphate.
Abbreviations used : GST, glutathione S-transferase ; DDCT, D-dopachrome tautomerase ; MIF, macrophage migration inhibitory factor ; EST, expressed sequence tag ; RFLP, restriction fragment length polymorphism. 1 To whom correspondence should be addressed (e-mail Philip.Board!anu.edu.au).
The nucleotide sequence data obtained in this study have been submitted to the GenBank, EMBL and DDBJ Nucleotide Sequence Databases with the accession numbers AN057172, AN057173, AN057174, AN057175 and AN057176.
GSTT2
and DDCT may contain a bidirectional promoter. The GSTT2 and DDCT genes have been duplicated in an inverted repeat. Sequence analysis of the duplicated GSTT2 gene has identified an exon 2\intron 2 splice site abnormality and a premature translation stop signal at codon 196. These changes suggest that the duplicate gene is a pseudogene, and it has been named GSTT2P.
Although structures have been reported for the rat rGSTT2 [17] and the mouse mGSTT2 genes [15] , almost nothing is known about the genomic organization of the human Theta-class GSTs or the factors that regulate their expression. The human GSTT1 gene is frequently deleted [12] , and around 16 % of Europeans are homozygous for this deletion [18] .
The present study describes the cloning, sequencing and structure of the human GSTT2 gene and a previously unknown GSTT2 pseudogene. During the course of this investigation, a gene encoding -dopachrome tautomerase (DDCT) was identified in close proximity to the GSTT2 gene. The DDCT gene is also duplicated in tandem with the GSTT2 pseudogene. The GSTT1 gene has been located approx. 50 kb away from the GSTT2\DDCT gene cluster, and has been shown to have an intron\exon structure similar to that of the GSTT2 gene.
EXPERIMENTAL Library screening
A human cosmid library [19] was screened by hybridization with a 767 bp cDNA fragment encoding human GSTT2 [14, 20] . A number of positive clones were isolated and analysed by restriction endonuclease digestion to identify appropriate fragments for subcloning. Two BamHI fragments (3.5 and 2.7 kb) and two SacI fragments (0.8 and 3.3 kb) that hybridized with the 767 bp cDNA fragment used for the library screening were isolated from the cosmid pT2cos2.
Cloning and sequencing
All fragments were subcloned into M13mp18 and M13mp19 for sequencing. Initial sequences were determined with vectorspecific primers, and these were extended using GSTT2-sequencespecific oligonucleotide primers. Direct sequencing of cosmid (19) clones was also carried out using a Thermosequenase cycle sequencing kit (Amersham). All exons and exon\intron boundaries were sequenced on both strands.
Identification of polymorphisms
Several differences between the GSTT2 cDNA and gene were identified during the sequencing process. 
RESULTS
A number of positive clones were identified by library screening and initially one cosmid, T2cos2, was subjected to further analysis. Restriction endonuclease digestion of the clone confirmed the presence of a previously identified strongly hybridizing 3.6 kb BamHI fragment and identified appropriate fragments for subcloning. Using both the subcloned DNA and direct sequencing of the cosmid DNA, the entire sequence of the encoded gene was determined. The exon\intron boundaries were identified by comparison with the cDNA sequence and the mouse GSTT2 gene [15] . The approximate start of transcription was estimated by analysis of cDNA clones identified in the EST (expressed sequence tag) database. Using the longest cDNA (accession no. W68102) as a 5h reference point and the polyA addition signal as Analysis of the sequence identified a number of variations that differed from the cDNA and splice consensus sequences. These included a G toA transition at nt 2669 changing Val-118 to Met in exon 4, a G to A transition at nt 2702 changing Glu-129 to Lys in exon 4, a G to A transition at nt 2732 changing Met-139 to Ile in exon 4, a C to T transition at nt 3255 changing Arg-196 to a stop codon in exon 5, and a G to A transition at nt 841, the first base of intron 2. The identification of an in-frame stop codon and a possible splice site defect in the gene sequence suggested that the gene encoded in T2cos2 may not be active and may be a pseudogene. Since the C to T transition causing the Arg-196 to Stop substitution in exon 5 from T2cos2 also created a new FokI site, it was possible to use PCR to amplify exon 5 DNA from additional cosmids and to use FokI digestion to determine if they contained genes encoding either Arg-196 or Stop196 (Figure 2 ). Two additional cosmids (T2cos8 and T2cos17) were selected for further study. T2cos8 contains an exon 5 sequence that encodes an Arg at codon 196. In contrast, exon 5 DNA amplified from T2cos17 contained sequences for both Arg-196 and Stop196.
Sequencing of T2cos8 confirmed the exon\intron structure found in T2cos2. In this case the exon\intron boundaries all agree with the established gt-ag consensus [21] , and are shown in Figure 3 . The exon sequence of the gene encoded in T2cos8 agreed with the cDNA sequence [14] , except for a G to A transition that results in a Met-139 Ile substitution. It seems highly likely that the gene in T2cos8 is the normal GSTT2 gene and that T2cos2 contains a previously undetected pseudogene, to be termed hereafter GSTT2P. The structures of both genes are shown schematically in Figure 4 . Since T2cos17 contains exon 5 DNA encoding both Arg-196 and Stop196, it appears that the gene and pseudogene are not allelic and are in relatively close proximity. Further studies were undertaken to determine their arrangement.
Restriction enzyme analysis of the three cosmid clones showed that they all contained a hybridizing 3.6 kb BamH1 fragment and hybridizing 0.77 kb and 3.3 kb SacI fragments. This suggests that the pseudogene has been generated by a duplication and that some of the flanking sequence has also been duplicated.
To determine the orientation of the two copies of exon 5 in T2cos17, oligonucleotide primers were prepared from the cosmid sequence on each side of the human genomic DNA insert (Cos F and Cos R ; Table 1 ). Long PCR amplification was performed using T2cos17 as a template with each of the cosmid primers paired with HTA5, an exon 5 primer from the sense strand of the GSTT2 sequence (Table 1 ). Both cosmid primers produced an amplified product. These products (approx. 4 kb and 9 kb) were gel-purified and used as a template with primers for the specific amplification of exon 5 DNA (HTA5 and HTB5 ; Table 1 ). The amplified products were digested with FokI in a manner similar to that shown in Figure 2 , and the results indicated that the two large amplified products each contained a copy of exon 5 from a different gene ; the 4 kb product contained the translation stop signal at codon 196 and the 9 kb product contained an Arg codon at that position. These data confirm that the two genes are present in T2cos17 and indicate that they are in different orientations. 
DDCT
DDCT converts 2-carboxy-2,3-dihydroindole-5,6-quinone (-dopachrome) into 5,6-dihydroxyindole, and is expressed widely in human tissues [22, 23] . Additional sequence from the 5h ends of the GSTT2 and GSTT2P genes was obtained from T2cos8 and T2cos2, and it was noted that both 5h flanking sequences contained the start of a gene encoding DDCT. In each case the DDCT gene is in the opposite orientation to its associated GSTT2 gene. The intervening sequence between the GSTT2 gene and its corresponding DDCT gene is shown in Figure 5 . It is evident from this sequence that there are no TATA or CAAT boxes in the 5h flanking regions of either gene. A search of this area for possible promoter sequences by application of the program Proscan : version 1.7 [24] (http :\\bimas.dcrt.nih.gov\molbio\proscan) predicted promoter regions between positions 26 and 276 on the forward strand and between positions 299 and 49 on the reverse strand. These overlapping regions contain a number of Sp1 sites that are commonly associated with promoters without TATA boxes.
Searches of the GenBank database also revealed that the cosmid T2cos17 overlaps with an unpublished human sequence from the clone BAC 322B1 (accession no. Z84718) obtained from chromosome 22 and an unpublished partial gene sequence for DDCT (accession no. Y11151). Comparison of these database sequences and sequence derived from T2cos17 with the DDCT cDNA sequence (accession no. U49785) allowed us to determine the structure and organization of the DDCT gene that is adjacent to GSTT2. The DDCT gene, illustrated in Figures 4 and 6 , extends over 8.5 kb and contains four exons. Since this gene sequence matches the cDNA and the intron\exon junctions are in agreement with the gt-ag rule [21] , it is probable that this is a functional gene. Because another DDCT gene can be found in association with the GSTT2P gene, it is clear that the duplication event that generated GSTT2P has included at least part of the associated DDCT gene. At this stage it is unclear whether the DDCT gene associated with GSTT2P is also a pseudogene.
Figure 7 Organization of the Theta-class GST and DDCT gene cluster
The diagram shows the relative positions and orientation of the genes and is not drawn to scale. The distance between GSTT1 and GSTT2 is approx. 50 kb. The information used to determine this gene arrangement has been derived from the overlapping clones T2cos17 and BAC 322B1. The positions of flanking cosmid primers used to determine the orientation of the GSTT2 and GSTT2P genes in T2cos17 are indicated.
Organization of the GSTT1, GSTT2 and DDCT genes and pseudogenes
We have previously shown that the genes encoding the two human Theta-class GST enzymes, GSTT1 and GSTT2, are both located on chromosome 22q11.2 [14, 25] . Examination of the BAC 322B1 sequence shows that GSTT1 and GSTT2 are separated by approx. 50 kb. Based on the longest available EST clone (accession no. AA300354), the GSTT1 gene is composed of five exons and spans 8.1 kb between nt 7816 and nt 15916 of the BAC sequence. A schematic diagram of the GSTT1 gene is shown in Figure 4 . Information derived from the overlapping BAC 322B1 and T2cos17 clones has allowed the organization of the GSTT1, GSTT2 and DDCT genes and pseudogene(s) to be determined. The relative position and orientation of each gene is summarized in Figure 7 . Because of the presence of repetitive sequence in the intervening region, the complete sequence between the DDCT genes has proved to be difficult to determine. However, long PCR using a single-sense primer from exon 4 of DDCT generated a 2.5 kb fragment, confirming the proximity of the two genes.
Polymorphism of GSTT2 and GSTT2P
Because we found a difference between the sequence of the cDNA and the GSTT2 gene that encoded an M139I substitution, we tested a sample of normal Australian European blood donors to determine if this substitution was the result of allelic variation. A 162 bp fragment from exon 4 was amplified with the primers HT4F and HTIPR (Table 1) and digested with NcoI. The G to A transition in codon 139 eliminates an NcoI site that can be detected by acrylamide electrophoresis of the digested PCR product (Figure 2) . The results of the survey are shown in Table  2 , and indicate that, with only four heterozygotes identified, the presence of the allele encoding isoleucine at codon 139 is relatively rare in the population sampled here.
We also tested the sample of blood donors for the presence of the GSTT2P gene by amplification of a 172 bp exon 5 fragment and digestion with FokI ( Figure 2 ). If both GSTT2 and GSTT2P are present, the pattern of FokI restriction fragments should contain equal amounts of exon 5 with and without the FokI site that marks the presence of the premature stop codon. The results of this survey are shown in Table 2 , and indicate that 28 % of individuals had both the GSTT2 gene and the GSTT2P gene, as indicated by the presence of the stop codon at position 196. The remaining 72 % had only the GSTT2 gene and showed no evidence for a gene with a stop codon at position 196. There are two possible explanations for these data. Either the gene duplication is polymorphic and is only present on some chromosomes ; alternatively, the substitution creating the stop codon in GSTT2P may itself be polymorphic. To differentiate between these two possibilities, we determined the frequency of the exon 2\intron 2 splice junction substitution in the same blood donors by PCR\ restriction fragment length polymorphism (RFLP) analysis (Figure 2) . The results of this study are shown in Table 2 , and indicate that, while 25 % of the group had the GSTT2 gene and at least one copy of a gene with the splice junction mutation, 74 % had the GSTT2 gene and presented no evidence for a gene with the splice mutation. In this case one individual (1 %) presented a restriction fragment pattern indicating the presence of the GSTT2P gene and the absence of the GSTT2 gene.
In 92 % of the individuals studied there was a direct correlation between the presence of the exon 2\intron 2 splice site mutation and the premature stop codon in exon 5. However, despite the obvious linkage of the splice site mutation and the premature stop codon, the presence of discordant individuals supports an argument in favour of allelic variation in GSTT2P. In fact, the individual that appears to only have the GSTT2P gene, based on the splice site genotype, is apparently heterozygous for the Arg-196 Stop mutation. This also supports the conclusion that the codon 196 variation in GSTT2P is polymorphic.
DISCUSSION
The human GSTT2 gene (3.7 kb) is intermediate in size between the rat Yrs gene (4 kb) [17] and the mouse GSTT2 gene (3.1 kb) [15] . Thus the subfamily 2 Theta-class genes appear to be about the same size as the Pi-class genes and notably smaller than the human Alpha-and Mu-class genes [26] [27] [28] [29] . In contrast, the human GSTT1 gene identified in BAC 322B1 extends over 8.1 kb. The structural organization of the rat and mouse subfamily 2 genes appears to be conserved in the human GSTT2 gene. All have five exons, and the positions of the exon\intron boundaries are conserved. The human GSTT1 gene also consists of five exons, and the positions of the introns are conserved between the GSTT1 and GSTT2 subfamilies.
Previous in situ hybridization studies have mapped both the GSTT1 and GSTT2 genes to chromosome 22q11.2, suggesting that the two genes are in close proximity [14, 25] . The results obtained from analysis of the BAC 322B1 and T2cos17 sequences have shown that GSTT1 and the GSTT2 genes are separated by approx. 50 kb. Given the differences in amino acid sequence between GSTT1 and GSTT2 (55 % identity), it appears that the 50 kb separation of the two genes may have restricted gene conversion events that tend to homogenize gene families.
The present study clearly indicates that the human GSTT2 gene has been duplicated, giving rise to a pseudogene GSTT2P that is in the opposite orientation and in close proximity. The conservation of the restriction enzyme sites in and around the GSTT2 and GSTT2P genes has obscured the presence of the gene duplication in the previous studies [28] . Pseudogenes have been previously identified in the Alpha-class gene cluster [30] , and a Pi-class reverse-transcribed pseudogene has also been described [31] .
The G to A transition at the first base of intron 2 of GSTT2P could result in defective splicing in i o, as the junction no longer conforms to the splice site consensus. Examination of the human EST databases confirmed the presence of a cDNA which has not been spliced at the end of exon 2 and runs into the intron sequence (accession no. W68102). The identification of this abnormally spliced cDNA in a foetal heart library suggests that the duplicated pseudogene may be transcribed. A search of the same EST database has not identified any cDNA clones carrying the exon 5 stop codon. However, if the transcripts of this gene are abnormally spliced they may utilize a different poly(A) addition signal that may exclude exon 5 sequence from the mature mRNA. Even if a complete mRNA containing the exon 5 stop codon was transcribed from the duplicated gene, it is probable that the product, truncated by 49 residues from the C-terminus, would be inactive. The recently determined crystal structure of GSTT2-2 shows that the C-terminal residues are part of a helix that packs across the active site [32] . In studies to be published elsewhere, it has been shown that the mutagenic deletion of 23 Cterminal residues inactivates the GSTT2 enzyme (J. Flanagan and P. Board, unpublished work). Similarly, a C-terminal deletion of residues from the Alpha-class enzyme GSTA1-1 has been shown to severely reduce its activity [33] . Therefore, although there is some evidence that GSTT2P is transcribed, it is unlikely that a functional product is expressed.
The sequence analysis carried out in the present study has identified and determined the structure of a gene encoding DDCT lying head-to-head with the GSTT2 gene. A similar gene occurs in the same relative orientation with respect to the GSTT2P gene. This indicates that the duplication that gave rise to GSTT2P was of sufficient size to include DDCT. We have not determined if both of the DDCT genes are functional. There are several sequences encoding DDCT in the EST database ; however, at this stage we have not been able to determine if they are the products of either or both of the DDCT genes.
The proximity and orientation of the GSTT2 and DDCT genes suggests that they may be under the control of a bidirectional promoter, such as those shown to occur within the mouse Surfeit locus [34, 35] . The Surf genes are a closely linked cluster of unrelated genes that are arranged in head-to-head pairs. It has been suggested that the Surf genes may be regulated by cisinteractions, including the sharing of regulatory elements, antisense regulation and promoter occlusion [35] . Examples of other divergently transcribed genes include the Wilms tumour genes WT1\Wit1 [36] , the ataxia telangiectasia genes ATM\E14 [37] , the collagen genes a1\a2 [38] , the Tap1\LMP2 genes [39] and the BRCA1 and NBR2 genes [40] . The Proscan search [24] of the DNA sequence between GSTT2 and DDCT identified overlapping regions on each DNA strand that could function as a bidirectional promoter. Further studies are clearly required to determine if transcription of GSTT2 and DDCT is co-ordinately regulated.
The conversion of -dopachrome into 5,6-dihydroxyindole is the only known enzymic activity of the enzyme DDCT [22, 23] . Since -dopachrome is not naturally occurring, it is highly likely that the enzyme has another, yet to be discovered, function and may in the future be more appropriately renamed. Amino acid sequence alignments have shown a degree of similarity (33 % identity) between DDCT and the cytokine termed macrophage migration inhibitory factor (MIF). Since MIF has been shown to have DDCT activity, it is likely that DDCT may have a similar physiological role to that of MIF [41] . Interestingly, MIF was previously suggested to show sequence similarities to Mu-and Theta-class GSTs, and was reported to have GST activity [42, 43] . Although an evolutionary relationship between MIF and the GSTs has been disputed [44] , the occurrence of a closely related gene (DDCT) within the Theta-class gene cluster is, if nothing else, an interesting coincidence. Furthermore the metabolism of dopachrome has been linked to the GSTs in a previous study [45] , where the Mu-class enzyme GSTM2-2 was shown to catalyse the conjugation of o-quinones such as dopachrome and adrenochrome to glutathione.
Approximately 16 % of Caucasians are homozygous for a deletion of the GSTT1 gene [18] . The survey of polymorphisms in the GSTT2 gene shown in Table 2 clearly indicates that GSTT2 is not commonly deficient and that the deletion of GSTT1 does not include GSTT2. The presence of a duplicated pseudogene makes formal genetic analysis of polymorphisms in the GSTT2 and GSTT2P loci difficult. PCR-RFLP techniques amplify identical products from both loci, and it is difficult to distinguish reliably between homozygotes and heterozygotes based on DNA fragment staining intensity. It has been difficult to determine whether the duplication giving rise to GSTT2P is polymorphic or whether the sites within the GSTT2P gene are polymorphic. Since there are individuals in which the abnormal splice site at the start of intron 2 and the stop codon at position 196 are discordant, it appears most likely that the sites in the GSTT2P gene are polymorphic. A study of the relative hybridization intensity of the 3.5 kb BamHI fragment failed to find any difference between individuals with and without the codon 196 stop sequence (results not shown). Thus it seems most likely that the GSTT2P gene occurs in all individuals and that the variant sites are polymorphic. During the present study one normal blood donor was identified with the GSTT2P gene, as indicated by the presence of the intron 2 splice defect, and showed no evidence for a normal gene. This individual may be deficient in GSTT2, and is under further investigation.
Although the Met-139 Ile substitution in GSTT2 was found to be a rare polymorphism in Australian Europeans, we considered the possibility that it may influence the enzyme's function. Modelling of this substitution in the recently solved crystal structure of GSTT2 [32] indicated that residue 139 is located in helix 5 and occupies a hydrophobic pocket that is bounded by Phe-110, Tyr-181, Pro-176, Pro-113 and Leu-183. The sub-stitution of isoleucine in this position is very unlikely to have a direct effect on the enzyme 's function, however, subtle secondary effects are difficult to predict and cannot be excluded.
